Literature DB >> 18078688

Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates.

Meztli D Arguello1, John Hiscott.   

Abstract

Conjugation of ubiquitin regulates multiple pathways, including the signaling cascades leading to antiviral immunity. Similarly, the ubiquitin-like peptide ISG15 mediates the antiviral response to certain viruses. In this issue of Cell Host & Microbe, Frias-Staheli and colleagues demonstrate that research on viral proteases of certain nairoviruses and arteriviruses reveals the presence of ovarian tumor domain-containing sequences that act as general deubiquitinases and deISGylases and increase viral replication by inhibiting the antiviral response mediated by ISG15.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078688     DOI: 10.1016/j.chom.2007.11.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  12 in total

Review 1.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin.

Authors:  Glenn C Capodagli; Marissa A McKercher; Erica A Baker; Emily M Masters; Joseph S Brunzelle; Scott D Pegan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

3.  Zebrafish ISG15 exerts a strong antiviral activity against RNA and DNA viruses and regulates the interferon response.

Authors:  C Langevin; L M van der Aa; A Houel; C Torhy; V Briolat; A Lunazzi; A Harmache; M Bremont; J-P Levraud; P Boudinot
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

4.  Fluorometric CCHFV OTU protease assay with potent inhibitors.

Authors:  Fatih Kocabas; Galip S Aslan
Journal:  Virus Genes       Date:  2015-07-09       Impact factor: 2.332

5.  Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.

Authors:  Suzanne Paz; Myriam Vilasco; Meztli Arguello; Qiang Sun; Judith Lacoste; Thi Lien-Anh Nguyen; Tiejun Zhao; Elena A Shestakova; Scott Zaari; Annie Bibeau-Poirier; Marc J Servant; Rongtuan Lin; Eliane F Meurs; John Hiscott
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

6.  The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process.

Authors:  Andrew Pincetic; Zhizhou Kuang; Eun Joo Seo; Jonathan Leis
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

7.  Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cells.

Authors:  Jonathan Leis; Chi-Hao Luan; James E Audia; Sara F Dunne; Carissa M Heath
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

8.  OTUB1 overexpression in mesangial cells is a novel regulator in the pathogenesis of glomerulonephritis through the decrease of DCN level.

Authors:  Yan Zhang; Ruimin Hu; Huijuan Wu; Weina Jiang; Yu Sun; Yan Wang; Yanan Song; Tong Jin; Hongxia Zhang; Xin Mao; Zhonghua Zhao; Zhigang Zhang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

9.  Epitope-based immunoinformatics and molecular docking studies of nucleocapsid protein and ovarian tumor domain of crimean-congo hemorrhagic Fever virus.

Authors:  Pappu Srinivasan; Sivakumar Prasanth Kumar; Muthusamy Karthikeyan; Jeyaram Jeyakanthan; Yogesh T Jasrai; Himanshu A Pandya; Rakesh M Rawal; Saumya K Patel
Journal:  Front Genet       Date:  2011-11-02       Impact factor: 4.599

10.  Identification of tyrosine-9 of MAVS as critical target for inducible phosphorylation that determines activation.

Authors:  Chaoyang Wen; Zhifeng Yan; Xiaoli Yang; Kai Guan; Changzhi Xu; Ting Song; Zirui Zheng; Wenjun Wang; Ying Wang; Man Zhao; Yanhong Zhang; Tao Xu; Jianping Dou; Jingmei Liu; Quanbin Xu; Xiang He; Congwen Wei; Hui Zhong
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.